Harmony Biosciences Holdings, Inc. (HRMY)

37.95 -0.32 (-0.84%) USD  |  NASDAQ  |  Oct 16, 16:00
37.96 0.00 (0.00%) After-Hours: 20:00
More

Harmony Biosciences Holdings Cash from Investing (Quarterly) : -131.50M for June 30, 2026

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -131.50M
March 31, 2026 -183.65M
December 31, 2025 -17.63M
September 30, 2025 -4.789M
June 30, 2025 -19.59M
March 31, 2025 2.362M
December 31, 2024 -7.187M
September 30, 2024 0.745M
June 30, 2024 -54.86M
March 31, 2024 -6.186M
December 31, 2023 -36.06M
September 30, 2023 -0.813M
June 30, 2023 -7.771M
March 31, 2023 -1.79M
December 31, 2022 -46.90M
Date Value
September 30, 2022 -32.44M
June 30, 2022 -22.45M
March 31, 2022 -40.04M
December 31, 2021 0.00
September 30, 2021 -0.093M
June 30, 2021 -0.201M
March 31, 2021 -100.00M
December 31, 2020 -2.00M
September 30, 2020 0.00
June 30, 2020 -0.002M
March 31, 2020 0.00
December 31, 2019 -77.04M
September 30, 2019 -0.03M
June 30, 2019 -0.051M
March 31, 2019 -50.03M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Liquidia Corp. -12.24M
Pfizer Inc. 2.106B
Bristol Myers Squibb Co. -1.614B
Repligen Corp. -2.089M
Johnson & Johnson --

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly) 92.43M
Cash from Financing (Quarterly) -0.558M
Free Cash Flow 335.65M
Free Cash Flow Per Share (Quarterly) 1.573
Free Cash Flow to Equity (Quarterly) 77.98M
Free Cash Flow to Firm (Quarterly) 94.92M
Free Cash Flow Yield 15.06%